Laurie Eliason - Value Evidence and Outcomes, GlaxoSmithKline

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 40 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

P-045 Idecabtagene Vicleucel (Ide-Cel) in Patients (pts) with Clinical High-Risk Early Relapse Multiple Myeloma (MM) Without Front-Line (1L) Autologous Stem Cell Transplantation (ASCT): KarMMA-2 Cohort 2B

Xavier Leleu,Alfred Chung,Noopur Raje,Meera Mohan,Reuben Benjamin,Adam Sperling, Larry Anderson,Madhav V. Dhodapkar,Shambavi Richard,Anna Truppel-Hartmann,Sarah Johnston,Fan Wu,Debashree Basudhar,Ethan Thompson,Devender Dhanda,Laurie Eliason, Sinhan Tran,Maria Chaudhry,Melissa Alsina

Clinical Lymphoma Myeloma and Leukemia (2024): S67

Cited0Views0Bibtex

Impact of Clinical Response and AEs on Health-Related Quality of Life (hrqol) in Patients (pts) with R/R Large B-cell Lymphoma (LBCL): Pooled Data from 4 Lisocabtagene Maraleucel (Liso-Cel) Trials

Patrick Connor Johnson,Jeremy S. Abramson,Ling Shi,Yeran Li,Laurie Eliason,Shien Guo, Fei,Leo I. Gordon

Journal of Clinical Oncologyno. 16_suppl (2024): 11105-11105

Cited0Views0Bibtex

Esther Natalie Oliva,Uwe Platzbecker,Matteo Giovanni Della Porta,Guillermo Garcia-Manero,Valeria Santini,Pierre Fenaux,Jake Shortt,Rami S. Komrokji,Christopher G. Pelligra,Shien Guo,Aylin Yucel,Mrudula B. Glassberg,Laurie Eliason, Ahmed Hnoosh,Dimana Miteva, Shelo Rose,Sandra Kreitz,Mikkael A. Sekeres,Amer M. Zeidan

Bloodno. Supplement 1 (2024): 3216-3216

Cited0Views0Bibtex

Establishing Meaningful Change Thresholds for European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire CLL-specific Module Domain Scores: an Analysis Based on the TRANSCEND CLL 004 Study in Patients with Relapsed or Refractory Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma

Laurie Eliason, Fatoumata Fofana,Lin Wang,Peter A. Riedell,Shien Guo

EJHaemno. 6 (2024): 1165-1172

Cited0Views0WOSBibtex

Idecabtagene Vicleucel (Ide-Cel) in Patients (pts) with Clinical High-Risk Early Relapse Multiple Myeloma (MM) Without Front-Line (1L) Autologous Stem Cell Transplantation (ASCT): KarMMA-2 Cohort 2B

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S67-S67

Cited0Views0Bibtex

Luspatercept Improves Fatigue-Related Quality of Life Through 5 Years of Treatment in Non-Transfusion Dependent Beta-Thalassemia

Khaled Musallam,Ali T. Taher, Ahmed Hnoosh,Laurie Eliason,Christopher G. Pelligra,Shien Guo,Yutian Mu,Maria Domenica Cappellini

Bloodno. Supplement 1 (2024): 3857-3857

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn